Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Noramco
Noramco
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Noramco announces strategic alignment with Purisys and Halo Pharma
The three organisations will provide North American supply chain solutions for clinical and commercial APIs and drug products
Manufacturing
Nemus finds US supplier for CBD-based retinal disease therapy
Controlled substance producer Noramco has been chosen to produce and scale up the new treatment
Ingredients
Noramco announces provisional patent application of proprietary cannabidiol (CBD)
Filing with the US Patent and Trademark Office covers pure cannabidiol compositions
Manufacturing
Development of patient friendly formulations agreement signed
Noramco and SPI Pharma have signed an agreement to develop and license a set of value-added formulation packages for global pharmaceutical manufacturers of finished dosage forms
Ingredients
Business going forward for Normaco
Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients announces major developments in its pharmaceutical offering at this year’s CPhI Worldwide
Ingredients
Noramco planning expansion in API market
Noramco will outline its business expansion plan at the Drug, Chemical and Associated Technologies Association (DCAT) meeting
Manufacturing
Aesica forms alliance with Noramco
For the manufacture of codeine
Subscribe now